Compendium of Assays for Immunodiagnosis of Human Cancer: Proceedings of the Workshop on the Immunodiagnosis of Human Cancer, National Institutes of Health, Bethesda, Maryland, Sept. 11-13, 1978Ronald B. Herberman |
From inside the book
Results 1-3 of 8
Page 197
... vivo cultivated tumor cells . Investigators : P. Koldovsky , M. Stark , H. Idel , H.W.Schlipköter Tumors : Digestive tract tumors . Bronchogenic carcinoma . Material : 1. Each tumor is separated in several parts : a . histology b ...
... vivo cultivated tumor cells . Investigators : P. Koldovsky , M. Stark , H. Idel , H.W.Schlipköter Tumors : Digestive tract tumors . Bronchogenic carcinoma . Material : 1. Each tumor is separated in several parts : a . histology b ...
Page 468
... sensitize . Use of Test in Combination with One or More Other Procedures : T - specific leukocyte migration assay and measurement of circulating anti - T antibodies . DISEASE STAGE TABLE 1 IN VIVO CELL - MEDIATED IMMUNE 468.
... sensitize . Use of Test in Combination with One or More Other Procedures : T - specific leukocyte migration assay and measurement of circulating anti - T antibodies . DISEASE STAGE TABLE 1 IN VIVO CELL - MEDIATED IMMUNE 468.
Page 546
... vivo by a carefully defined series of skin tests with tumor - associated antigens ( TAA ) for mea- surement of and pathological evaluation of delayed hypersensitivity reac- tions ( DHR - ST ) and as measured in vitro by determining the ...
... vivo by a carefully defined series of skin tests with tumor - associated antigens ( TAA ) for mea- surement of and pathological evaluation of delayed hypersensitivity reac- tions ( DHR - ST ) and as measured in vitro by determining the ...
Contents
SUMMARY OF DISCUSSION ON GENERAL ASSAYS FOR | 3 |
SERUM CARCINOEMBRYONIC ANTIGEN CEA | 13 |
SERUM CARCINOEMBRYONIC ANTIGEN CEA | 27 |
Copyright | |
69 other sections not shown
Common terms and phrases
adenocarcinoma antibody antisera antiserum Assay Characteristics Assay for Screening Assay in Initial Assay Performed Assays for Immunodiagnosis associated antigens autologous benign breast disease benign disease breast cancer breast cancer patients Brief Description Burden or Extent C3DP calcitonin CEA assay CEA levels cell line ceruloplasmin cervical cervical cancer Characteristics of Marker chemotherapy colon Compendium of Assays correlation Description of Assay detected EDC1 elevated Evidence for Relationship Extent of Disease false positives ferritin fetal glycoprotein Herberman immune complexes Immunodiagnosis of Human Initial Diagnosis Initial Staging Known Markers leukocytes liver lung cancer Main Unresolved Issues malignant melanoma cells metastatic ng/ml normal donors ovarian cancer postoperatively present protein purified rabbit radioimmunoassay reactions reactivity recurrence responses samples sarcoma secretory component sensitivity sera Serial Monitoring serum skin test Sources of False specific squamous Staging of Disease studies surgery Table Therapeutic Decisions therapy titer tumor burden tumor cells